IMNN Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Imunon Inc (IMNN) is not a good buy for a beginner investor with a long-term strategy and $50,000-$100,000 available for investment. The stock shows weak technical indicators, no positive trading trends, poor financial performance, and lacks any recent news or catalysts to support a bullish outlook. Given the lack of strong signals and the investor's preference for long-term investments, holding off on this stock is recommended.
The technical indicators for IMNN are bearish. The MACD is negatively expanding below 0, the RSI is neutral at 21.078, and the moving averages are in a bearish alignment (SMA_200 > SMA_20 > SMA_5). The stock is trading near its pivot level of 2.893, with resistance levels at 3.167 and 3.336, and support levels at 2.619 and 2.449. Overall, the trend suggests weakness in the stock's price movement.
NULL. No recent news, no significant trading trends, and no congress trading data available.
The stock has shown a -2.52% regular market change and a bearish technical setup. Financial performance is weak, with a significant drop in net income (-29.23% YoY) and EPS (-76.94% YoY). There are no positive trading trends from hedge funds or insiders.
In Q3 2025, the company's revenue remained at 0 with no growth YoY. Net income dropped significantly to -3,429,124 (-29.23% YoY), and EPS fell sharply to -1.01 (-76.94% YoY). Gross margin was also 0, showing no improvement. Overall, the financial performance is poor.
No analyst rating or price target changes are available. There is no Wall Street sentiment or guidance on the stock.
